Deutsche Bank’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Buy
40,596
+7,190
+22% +$236K ﹤0.01% 2022
2025
Q4
$1.06M Buy
33,406
+9,176
+38% +$276K ﹤0.01% 2161
2025
Q3
$569K Buy
24,230
+3,927
+19% +$67.3K ﹤0.01% 2481
2025
Q2
$230K Sell
20,303
-5,263
-21% -$50K ﹤0.01% 2881
2025
Q1
$170K Sell
25,566
-325,048
-93% -$3.03M ﹤0.01% 3028
2024
Q4
$3.87M Sell
350,614
-111,861
-24% -$1.37M ﹤0.01% 1463
2024
Q3
$5.68M Buy
462,475
+446,445
+2,785% +$6.32M ﹤0.01% 1231
2024
Q2
$217K Sell
16,030
-396,210
-96% -$5.35M ﹤0.01% 2762
2024
Q1
$5.57M Sell
412,240
-538
-0.1% -$3.26K ﹤0.01% 1224
2023
Q4
$2.17M Buy
412,778
+399,016
+2,899% +$1.71M ﹤0.01% 1637
2023
Q3
$54.2K Sell
13,762
-556,749
-98% -$3.66M ﹤0.01% 3393
2023
Q2
$6.06M Sell
570,511
-146,406
-20% -$1.56M ﹤0.01% 1173
2023
Q1
$5.97M Sell
716,917
-30,869
-4% -$278K ﹤0.01% 1165
2022
Q4
$6.9M Sell
747,786
-39,099
-5% -$407K ﹤0.01% 1106
2022
Q3
$10.1M Sell
786,885
-1,496
-0.2% -$23.8K 0.01% 952
2022
Q2
$10.4M Buy
788,381
+516,495
+190% +$7.85M 0.01% 981
2022
Q1
$5.72M Buy
271,886
+247,555
+1,017% +$4.96M ﹤0.01% 1356
2021
Q4
$584K Sell
24,331
-2,864
-11% -$68.3K ﹤0.01% 2736
2021
Q3
$693K Buy
27,195
+14,628
+116% +$408K ﹤0.01% 2846
2021
Q2
$423K Buy
12,567
+3,499
+39% +$124K ﹤0.01% 3329
2021
Q1
$352K Sell
9,068
-141
-2% -$8.03K ﹤0.01% 3322
2020
Q4
$570K Buy
9,209
+2,474
+37% +$113K ﹤0.01% 2824
2020
Q3
$225K Buy
6,735
+590
+10% +$16.8K ﹤0.01% 3155
2020
Q2
$146K Buy
6,145
+235
+4% +$5.58K ﹤0.01% 3272
2020
Q1
$135K Buy
5,910
+2,659
+82% +$65.7K ﹤0.01% 3129
2019
Q4
$91K Buy
3,251
+426
+15% +$10.7K ﹤0.01% 3631
2019
Q3
$59K Buy
+2,825
New +$78.8K ﹤0.01% 3839

Other funds holding STOK